Revello™ Vascular Covered Stent
Search documents
BD Board Increases Dividend for 54th Consecutive Year
Prnewswire· 2025-11-06 11:25
Accessibility StatementSkip Navigation SOURCE BD (Becton, Dickinson and Company) 21% more press release views with Request a Demo FRANKLIN LAKES, N.J., Nov. 6, 2025 /PRNewswire/ -- The Board of Directors of BD (Becton, Dickinson and Company) (NYSE: BDX) has declared a quarterly dividend of $1.05 per common share, an increase of 1.0% from the previous quarter. The dividend will be payable on December 31, 2025 to holders of record on December 8, 2025. The indicated annual dividend rate for fiscal year 2026 ...
BD Achieves Milestone in AGILITY Study of Revello™ Vascular Covered Stent for Treatment of Peripheral Artery Disease
Prnewswire· 2025-11-04 11:50
Accessibility StatementSkip Navigation FRANKLIN LAKES, N.J., Nov. 4, 2025 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, announced full enrollment of the iliac artery patient cohort in its pivotal AGILITY Investigational Device Exemption (IDE) study, a prospective, multi-center study evaluating the Revelloâ"¢ Vascular Covered Stent in patients with peripheral arterial disease (PAD). Continue Reading BD Achieves Milestone in AGILITY Study of Revel ...